Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity
Br J Ophthalmol
.
2009 Jul;93(7):986.
doi: 10.1136/bjo.2008.156208.
Authors
B A Darlow
,
C Gilbert
,
G E Quinn
,
R Azad
,
A L Ells
,
A Fielder
,
A Zin
PMID:
19553518
DOI:
10.1136/bjo.2008.156208
No abstract available
Publication types
Letter
MeSH terms
Humans
Infant, Newborn
Retinopathy of Prematurity / drug therapy*
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Substances
Vascular Endothelial Growth Factor A